leisure time -WSS

leisure time

author：fashion 2025-10-01 02:28:09 - browse：36393

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： In Memoriam: Notable people who died in 2023

focus

WSS

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Virginia high school admissions case could be legal follow

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Assistant physicians can help address the primary care shortage

The unintended consequences of overturning Roe v. Wade

People with substance use disorder deserve online privacy

leisure time

leisure time

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Trump demands the U.S. pay no more for drugs than other countries … again

What does generative AI mean for health care? We asked experts

How to save PrEP access — and even expand it

Psychedelics group wrestles with new pharma identity

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare details structure of new drug price negotiation program

Continuity nursing helped my family in our darkest PICU moments

The high cost of giving birth even with insurance

Chamber of Commerce, DOJ clash in court over drug prices

hotspot

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

DIEP, the 'gold standard' of breast reconstruction, is under threat

The cancer drug shortage isn’t new — and neither are the solutions

House panel takes first step toward fixing drug shortages

Covid’s new normal has set in amid another rise in cases

Apple is now the first public company to be valued at $3 trillion

focus

focus

Wikipedia

entertainment